Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca²⁺/Calcineurin/p-NFATc3 Pathway

Figure 3

mRNA and expression levels of ANP and BNP proteins in cardiomyocytes of each group.

(a)

(b)